• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺癌更新指南——证据与医疗现实之间的平衡之举]

[Update guideline on prostate cancer-balancing act between evidence and healthcare reality].

作者信息

Belusa Axel, Goebell Peter J, Kollenbach Peter, Faßbach Mira, Kühne Peter, El-Khadra Sulafah, Quack Thomas, Kramer Mario

机构信息

Berufsverband der Deutschen Urologie e. V. (BvDU), Glinkastr. 32, 10117, Berlin, Deutschland.

出版信息

Urologie. 2025 Sep;64(9):968-972. doi: 10.1007/s00120-025-02662-x. Epub 2025 Aug 20.

DOI:10.1007/s00120-025-02662-x
PMID:40833587
Abstract

The update of the guideline on prostate cancer has been and continues to be discussed in all its facets, even with passion.One source of the dispute about some of the content of the current guideline is undoubtedly the lack of precision with which terms were introduced in the past and are still communicated incorrectly and vaguely to this day.In this article, the Professional Association of German Urology (BvDU) discusses five key points with professional policy relevance and where the implementation of the guideline meets the reality of care.

摘要

前列腺癌指南的更新一直以来都在各个方面被讨论着,甚至讨论得十分热烈。当前指南某些内容引发争议的一个根源无疑是,过去引入的术语缺乏精准性,至今仍被错误且模糊地传达。在本文中,德国泌尿外科学会(BvDU)讨论了五个与专业政策相关的关键点,以及指南的实施与医疗实际情况的契合点。

相似文献

1
[Update guideline on prostate cancer-balancing act between evidence and healthcare reality].[前列腺癌更新指南——证据与医疗现实之间的平衡之举]
Urologie. 2025 Sep;64(9):968-972. doi: 10.1007/s00120-025-02662-x. Epub 2025 Aug 20.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
4
Screening for prostate cancer.前列腺癌筛查
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004720. doi: 10.1002/14651858.CD004720.pub3.
5
Complementary medicine in guidelines of the German Guideline Program in Oncology: comparison of the evidence base between complementary and conventional therapy. huebner@med.uni-frankfurt.de.补充医学在德国肿瘤学指南项目指南中的应用:补充和常规治疗之间证据基础的比较。huebner@med.uni-frankfurt.de。
J Cancer Res Clin Oncol. 2013 Sep;139(9):1481-8. doi: 10.1007/s00432-013-1464-7. Epub 2013 Jul 2.
6
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
7
Sexual Harassment and Prevention Training性骚扰与预防培训
8
The Early Detection, Diagnostic Evaluation, and Local Treatment of Prostate Cancer: A Paradigm Shift.前列腺癌的早期检测、诊断评估及局部治疗:范式转变
Dtsch Arztebl Int. 2025 Jul 5;122(15):420-426. doi: 10.3238/arztebl.m2025.0099.
9
[National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].[国家S3非复杂性尿路感染指南:成人患者非复杂性社区获得性细菌性尿路感染的治疗与管理建议]
Urologe A. 2011 Feb;50(2):153-69. doi: 10.1007/s00120-011-2512-z.
10
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.

本文引用的文献

1
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.比较数字直肠检查和前列腺特异性抗原作为前列腺癌筛查试验的性能:系统评价和荟萃分析。
Eur Urol Oncol. 2024 Aug;7(4):697-704. doi: 10.1016/j.euo.2023.12.005. Epub 2024 Jan 4.
2
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer.直肠指检对前列腺癌不是一种有用的筛查试验。
Eur Urol Oncol. 2023 Dec;6(6):566-573. doi: 10.1016/j.euo.2023.09.008. Epub 2023 Oct 6.